Jacobs Levy Equity Management, Inc Aurinia Pharmaceuticals Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q1 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 317,656 shares of AUPH stock, worth $2.82 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
317,656
Previous 13,236
2299.94%
Holding current value
$2.82 Million
Previous $118,000
2063.56%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AUPH
# of Institutions
240Shares Held
65.2MCall Options Held
1.1MPut Options Held
772K-
Tang Capital Management LLC San Diego, CA10MShares$89.1 Million5.24% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$82.3 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5MShares$44.4 Million0.61% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$35.3 Million3.03% of portfolio
-
State Street Corp Boston, MA2.85MShares$25.3 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.26B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...